Cart
sales@molnova.com
ODM-207
CAS No. 1801503-93-4
ODM-207( BET-IN-4 | ODM-207 | ODM207 )
Catalog No. M26070 CAS No. 1801503-93-4
BET-IN-4 is a potent BRD4 inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 5MG | 84 | In Stock |
|
| 10MG | 136 | In Stock |
|
| 25MG | 249 | In Stock |
|
| 50MG | 351 | In Stock |
|
| 100MG | 496 | In Stock |
|
| 200MG | 682 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameODM-207
-
NoteResearch use only, not for human use.
-
Brief DescriptionBET-IN-4 is a potent BRD4 inhibitor.
-
DescriptionBET-IN-4 is a potent BRD4 inhibitor.(In Vitro):BET-IN-4 inhibits BRD4 with an IC50 of ≤ 1 μM.
-
In VitroODM-207 (Compound 50) is a potent BET bromodomain protein (BRD4) inhibitor, with an IC50 of ≤ 1 μM.
-
In Vivo——
-
SynonymsBET-IN-4 | ODM-207 | ODM207
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1801503-93-4
-
Formula Weight375.428
-
Molecular FormulaC22H21N3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (26.64 mM)
-
SMILESCOc1cc2n(Cc3ccccn3)c(=O)c(C)cc2cc1-c1c(C)noc1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kao-Lu Pan, et al. Identification of trans,trans-2,4-decadienal metabolites in mouse and human cells using liquid chromatography-mass spectrometry. Chem Res Toxicol. 2014 Oct 20;27(10):1707-19.
molnova catalog
related products
-
GSK046
GSK046 is a potent, selective and orally active BD2 bromodomain inhibitor of the BET proteins(IC50s of 264 nM (BRD2 BD2), 98 nM (BRD3 BD2), 49 nM (BRD4 BD2) and 214 nM (BRDT BD2), respectively).
-
C-82
C-82 is a specific CBP/β-catenin antagonist. It inhibits the binding between β-catenin and CBP and increases the binding between β-catenin and p300.
-
Y06137
Y06137 is an effective and selective BET inhibitor with a Kd of 81 nM for BRD4(1) bromodomain. Y06137 can be used for research on the treatment of castration-resistant prostate cancer.
